| Ki | - | 
                
                    | EC50 |  | 
                
                    | IC50 | 2.13±0.01 μM(EaAChE),  1.8±0.02 μM(RatAChE),  3.82±0.05 μM(HuAChE),  0.021±0.0005 μM(EqBCHE),  8.63±0.03 μM(RatBCHE),  0.07±0.01 μM(HuBCHE) | 
                
                    | Inhibition | 68.7±0.76%(Self-induced Aβ1-42  aggregation , 50μM),  50.8±0.81%(Self-induced Aβ1-42  aggregation , 25μM),  31.2±0.05%(Self-induced Aβ1-42  aggregation , 12.5μM) | 
                
                    | Toxicity | Low toxicity | 
                
                    | ROS(reactive oxygen species) |  | 
                
                    | Metal Chelating |  | 
                
                    | BBB(blood-brain barrier) | PASS | 
                
                    | Target Protein | Acetylcholinesterase (AChE) | 
                
                    | Effects | Inhibit Aβ1-42  fibrils formation,  inhibit self-induced Aβ aggregation and disassemble the well-structured Aβ fibrils,  had a wide therapeutic safety range on PC12 cells,  improved cognitive deficit induced by scopolamine through increasing brain cholinergic activity | 
                
                    | Research Models | Docking studies,  in PC12 cells,  in vitro | 
                
                    | Ref. Link |  |